Policy commentary argues for editorial retraction of irreproducible studies without misconduct, highlighting the need to correct the scientific record and maintain literature validity.
There have been a number of high-profile cases of retraction involving papers reporting important breakthroughs subsequently found to be irreproducible. In cases such as that of the ‘Arsenic-life’ bacteria, the papers have no identified major factual errors or associated scientific misconduct, and it is debatable whether editorial retraction is justified. I contend that retractions, based solely on irreproducibility, would be appropriate in principle. This is because interpretive errors have occurred at the very least, and these errors owe largely to inadequate or erroneous data/findings generated by the authors themselves. The literature should thus be corrected to maintain validity and accuracy.
No takes yet. Share an insight, caveat, or question.
Bor Luen Tang (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: